0 708

Cited 9 times in

Cited 8 times in

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

DC Field Value Language
dc.contributor.authorHan, Eugene-
dc.contributor.authorHuh, Ji Hye-
dc.contributor.authorLee, Eun Y.-
dc.contributor.authorBae, Ji C.-
dc.contributor.authorChun, Sung W.-
dc.contributor.authorYu, Sung H.-
dc.contributor.authorKwak, Soo H.-
dc.contributor.authorPark, Kyong S.-
dc.contributor.authorLee, Byung Wan-
dc.date.accessioned2022-05-09T17:01:14Z-
dc.date.available2022-05-09T17:01:14Z-
dc.date.created2022-05-24-
dc.date.issued2022-04-
dc.identifier.issn1462-8902-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188336-
dc.description.abstract[No abstract available]-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherWiley-Blackwell-
dc.relation.isPartOfDiabetes, Obesity and Metabolism-
dc.relation.isPartOfDIABETES OBESITY & METABOLISM-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEfficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorHan, Eugene-
dc.contributor.googleauthorHuh, Ji Hye-
dc.contributor.googleauthorLee, Eun Y.-
dc.contributor.googleauthorBae, Ji C.-
dc.contributor.googleauthorChun, Sung W.-
dc.contributor.googleauthorYu, Sung H.-
dc.contributor.googleauthorKwak, Soo H.-
dc.contributor.googleauthorPark, Kyong S.-
dc.contributor.googleauthorLee, Byung Wan-
dc.identifier.doi10.1111/dom.14623-
dc.relation.journalcodeJ00722-
dc.identifier.eissn1463-1326-
dc.subject.keyworddipeptidyl peptidase-4 inhibitor-
dc.subject.keywordevogliptin-
dc.subject.keywordmagnetic resonance imaging-derived proton density fat fraction-
dc.subject.keywordnon-alcoholic fatty liver disease-
dc.subject.keywordpioglitazone-
dc.subject.keywordtype 2 diabetes-
dc.contributor.alternativeNameLee, Byung Wan-
dc.contributor.affiliatedAuthorLee, Byung Wan-
dc.identifier.scopusid2-s2.0-85121698174-
dc.identifier.wosid000734621400001-
dc.citation.volume24-
dc.citation.number4-
dc.citation.startPage752-
dc.citation.endPage756-
dc.identifier.bibliographicCitationDiabetes, Obesity and Metabolism, Vol.24(4) : 752-756, 2022-04-
dc.identifier.rimsid74007-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthordipeptidyl peptidase-4 inhibitor-
dc.subject.keywordAuthorevogliptin-
dc.subject.keywordAuthormagnetic resonance imaging-derived proton density fat fraction-
dc.subject.keywordAuthornon-alcoholic fatty liver disease-
dc.subject.keywordAuthorpioglitazone-
dc.subject.keywordAuthortype 2 diabetes-
dc.subject.keywordPlusSITAGLIPTIN-
dc.subject.keywordPlusMODEL-
dc.subject.keywordPlusRISK-
dc.type.docTypeLetter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryEndocrinology & Metabolism-
dc.relation.journalResearchAreaEndocrinology & Metabolism-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.